Condition: Myelofibrosis · Anemia · Sponsor: Takeda
The main aim of this study is to find out how well elritercept works to improve anemia in participants with myelofibrosis (MF) who are taking ruxolitinib when compared to placebo. Other aims are to learn how elritercept improves anemia compared to placebo; to learn if elritercept reduces tiredness, improves symptoms related to MF, and helps participants do physical activities more easily. The study also aims to find out how elritercept affects the bone marrow, the spleen, and whether participants develop antibodies to the study drug. The study will also check how safe elritercept is compared to placebo, and if elritercept stays safe over a long period of time. Participants will receive study treatment for at least 9 months (36 weeks). After this period, participants who received placebo will have the option to switch to elritercept.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Los Angeles Cancer Network | Glendale, California, United States | Not Yet Recruiting |
| Cancer and Blood Specialty Clinic | Whittier, California, United States | Not Yet Recruiting |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Advanced Research, LLC | Coral Springs, Florida, United States | Not Yet Recruiting |
| Bioresearch Partners | Miami, Florida, United States | Not Yet Recruiting |
| AdventHealth - Cancer Institute - Orlando | Orlando, Florida, United States | Not Yet Recruiting |
| Florida Clinical Trials Group | Tamarac, Florida, United States | Not Yet Recruiting |
| Moffit Cancer Center | Tampa, Florida, United States | Not Yet Recruiting |
| Emory University | Atlanta, Georgia, United States | Not Yet Recruiting |
| Tufts Medical Center | Boston, Massachusetts, United States | Not Yet Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Not Yet Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Not Yet Recruiting |
+ 195 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07623161